Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern (Q79745026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Tu K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Campbell NR

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Chen Z

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

McAlister FA

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

8 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

271-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17287848%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002128

25 December 2019

exact match

0 references

cites work

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

The end of beta blockers for uncomplicated hypertension?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

The Impact of the Canadian Hypertension Education Program on Antihypertensive Prescribing Trends

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Polytherapy with two or more antihypertensive drugs to lower blood pressure in elderly Ontarians. Room for improvement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

The Canadian Hypertension Education Program--a unique Canadian initiative

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Implementation of recommendations on hypertension: the Canadian Hypertension Education Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

The Outcomes Research Task Force and the Canadian Hypertension Education Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Socioeconomic differentials in mortality: evidence from Glasgow graveyards

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Socioeconomic factors and cardiovascular disease: a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Atenolol in hypertension: is it a wise choice?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021

Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002128

7 January 2021